Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
LEXICON PHARMACEUTICALS, INC. (LXRX)
Sector: Healthcare; Industry: Biotechnology

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-16 Artal International S.C.A. 10%-Owner, Director Buy 10,937,500 $3.20 $35,000,000 No
2020-12-16 Invus Public Equities, L.P. 10%-Owner, Director Buy 10,937,500 $3.20 $35,000,000 No
2019-09-18 COATS LONNEL President and CEO Buy 50,000 $3.10 $155,000 No
2019-09-18 Santini Alexander A EVP and CCO Buy 4,500 $3.36 $15,115 No
2019-09-17 COATS LONNEL President and CEO Buy 50,000 $3.13 $156,403 No
2019-09-16 DEBBANE RAYMOND Director Buy 103,042 $2.69 $277,591 No
2019-09-13 DEBBANE RAYMOND Director Buy 197,473 $2.40 $474,760 No
2019-09-16 SOBECKI CHRISTOPHER J Director Buy 25,000 $2.55 $63,718 No
2019-09-13 SOBECKI CHRISTOPHER J Director Buy 99,249 $2.41 $238,750 No
2019-08-19 COATS LONNEL President and CEO Buy 40,000 $1.35 $54,029 No
2019-08-02 Tessmer James F VP, Finance & Accounting Buy 10,000 $1.14 $11,400 No
2019-08-02 BARKER SAM L Director Buy 24,000 $1.18 $28,200 No
2018-06-28 Invus Public Equities, L.P. 10%-Owner, Director Buy 182,838 $12.51 $2,287,377 No
2018-06-25 Invus Public Equities, L.P. 10%-Owner, Director Buy 253,725 $12.99 $3,295,173 No
2018-06-21 Invus Public Equities, L.P. 10%-Owner, Director Buy 72,973 $13.29 $970,045 No
2018-06-18 Invus Public Equities, L.P. 10%-Owner, Director Buy 45,784 $12.98 $594,399 No
2018-06-12 Invus Public Equities, L.P. 10%-Owner, Director Buy 235,396 $12.80 $3,014,123 No
2018-06-08 Tessmer James F VP, Finance & Accounting Sell 10,000 $12.91 $129,076 Yes
2018-06-07 Invus Public Equities, L.P. 10%-Owner, Director Buy 325,639 $12.58 $4,095,065 No
2018-06-04 Invus Public Equities, L.P. 10%-Owner, Director Buy 416,481 $12.01 $5,002,667 No
2018-05-30 Invus Public Equities, L.P. 10%-Owner, Director Buy 433,378 $9.94 $4,306,418 No
2018-05-23 Santini Alexander A EVP and CCO Buy 745 $9.78 $7,286 No
2017-11-17 Invus Public Equities, L.P. 10%-Owner, Director Buy 180,727 $10.11 $1,826,896 No
2017-11-15 COATS LONNEL President and CEO Buy 10,000 $9.91 $99,100 No
2017-11-14 Invus Public Equities, L.P. 10%-Owner, Director Buy 575,946 $9.64 $5,554,166 No
2017-11-14 WADE JEFFREY L EVP, Corp Adm Affairs and CFO Buy 2,000 $9.48 $18,962 No
2017-09-15 COATS LONNEL President and CEO Buy 30,000 $12.54 $376,337 No
2017-09-15 BARKER SAM L Director Buy 1,000 $12.50 $12,500 No
2016-06-06 Tessmer James F VP, Finance & Accounting Sell 1,500 $15.00 $22,500 Yes
2016-05-23 Tessmer James F VP, Finance & Accounting Sell 6,000 $13.00 $78,000 Yes

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.